SCHEMBL3510930

SCHEMBL3510930

O=C(O)Cc1ccc(Cl)c(Oc2ccccc2OC/C=C/c2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 3/20 0.46
PSEN1 P49768 2/20 0.45
PTGES O14684 1/20 0.45
ALOX5 P09917 1/20 0.45
PPARG P37231 1/20 0.45
S1PR5 Q9H228 3/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
RXRG P48443 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40
PSENEN Q9NZ42 1/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.39
DRD2 P14416 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3510935 1.00 PPARD (0.46) PPARDPSEN1PTGESALOX5PPARG
SCHEMBL3506173 0.89 PPARG (0.47) PPARDPSEN1PTGESALOX5PPARG
SCHEMBL3506168 0.89 PPARG (0.47) PPARDPSEN1PTGESALOX5PPARG
SCHEMBL3506083 0.87 PPARG (0.46) PPARDPSEN1PTGESALOX5PPARG
SCHEMBL3506077 0.87 PPARG (0.46) PPARDPSEN1PTGESALOX5PPARG
SCHEMBL3510809 0.86 S1PR5 (0.43) PSEN1PTGESALOX5PPARGS1PR5
SCHEMBL3510805 0.86 S1PR5 (0.43) PSEN1PTGESALOX5PPARGS1PR5
SCHEMBL3508633 0.85 PPARG (0.50) PPARDPSEN1PTGESALOX5PPARG
SCHEMBL3508636 0.85 PPARG (0.50) PPARDPSEN1PTGESALOX5PPARG
SCHEMBL3506401 0.84 PPARG (0.46) PPARDPSEN1PTGESALOX5PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267778-A1 Diphenyl ether compound, process for producing the same, and use ONO PHARMACEUTICAL CO., LTD. (JP) 2010-10-21 US disclosed
EP-1661879-A1 DIPHENYL ETHER COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE ONO PHARMACEUTICAL CO., LTD. (JP) 2006-05-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267778-A1 Diphenyl ether compound, process for producing the same, and use PPARG, PPARD, PPARA PPARD 2/4885PSEN1 3599/4885PTGES 218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.